Aquestive Therapeutics, Inc.
AQSTDrug Manufacturers - Specialty & Generic
$4.04−4.49%As of Oct 29vs prior close
- Market cap
- $507.1M
- P/E (TTM)
- –
- From 52W high
- −40.76%
- EPS (LTM)
- -$0.65
- Revenue (LTM)
- $54.1M
- Net margin
- -144.63%
- Dividend yield
- 0.00%
Nomior Score
16
Fragile PremiumSpeculativeBottom 5% of the scored universe
Growth59
Quality19
Value21
Momentum28
Resilience30
Growth
−4.96%revenue a year over 8 fiscal years
YE17 $66.9MLTM $54.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 60% of revenue, narrower by 54 pts on a year.
Who owns it
2funds